Nomura Holdings’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-467,818
| Closed | -$6.08K | – | 1730 |
|
|
2024
Q3 | $6.08K | Hold |
467,818
| – | – | ﹤0.01% | 868 |
|
|
2024
Q2 | $19.6K | Hold |
467,818
| – | – | ﹤0.01% | 1073 |
|
|
2024
Q1 | $24.3K | Hold |
467,818
| – | – | ﹤0.01% | 928 |
|
|
2023
Q4 | $0 | Hold |
467,818
| – | – | ﹤0.01% | 1411 |
|
|
2023
Q3 | $0 | Hold |
467,818
| – | – | ﹤0.01% | 1128 |
|
|
2023
Q2 | $60.8K | Hold |
467,818
| – | – | ﹤0.01% | 700 |
|
|
2023
Q1 | $51.5K | Hold |
467,818
| – | – | ﹤0.01% | 806 |
|
|
2022
Q4 | $53K | Hold |
467,818
| – | – | ﹤0.01% | 811 |
|
|
2022
Q3 | $62K | Hold |
467,818
| – | – | ﹤0.01% | 908 |
|
|
2022
Q2 | $87K | Hold |
467,818
| – | – | ﹤0.01% | 1003 |
|
|
2022
Q1 | $196K | Buy |
+467,818
| New | +$196K | ﹤0.01% | 1130 |
|